{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:44:57Z","timestamp":1772833497100,"version":"3.50.1"},"reference-count":15,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.3892\/ol.2011.369","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T10:56:55Z","timestamp":1312282615000},"page":"1239-1242","source":"Crossref","is-referenced-by-count":6,"title":["Long-term efficacy of oral alendronate therapy in an elderly patient with polyostotic fibrous dysplasia: A case report"],"prefix":"10.3892","volume":"2","author":[{"given":"GUI-DONG","family":"LI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIRA","family":"OGOSE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TETSUO","family":"HOTTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROYUKI","family":"KAWASHIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"ARIIZUMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YONGJUN","family":"XU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAOTO","family":"ENDO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2011,8,2]]},"reference":[{"key":"key20180108093704_b1-ol-02-06-1239","first-page":"1059","article-title":"Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia","volume":"150","author":"Marie","year":"1997","journal-title":"Am J Pathol"},{"key":"key20180108093704_b2-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S8756-3282(03)00064-4","article-title":"Osteoclastogenesis in fibrous dysplasia of bone: In situ and in vitro analysis of IL-6 expression","volume":"33","author":"Riminucci","year":"2003","journal-title":"Bone"},{"key":"key20180108093704_b3-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003086-200101000-00003","article-title":"Bisphosphonate therapy in fibrous dysplasia","volume":"382","author":"Lane","year":"2001","journal-title":"Clin Orthop"},{"key":"key20180108093704_b4-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-001-1098-7","article-title":"Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia","volume":"71","author":"Isaia","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"key20180108093704_b5-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2004.03.004","article-title":"Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment","volume":"35","author":"Chapurlat","year":"2004","journal-title":"Bone"},{"issue":"Suppl 2","key":"key20180108093704_b6-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1359\/jbmr.06s222","article-title":"Medical therapy in adults with fibrous dysplasia of bone","volume":"21","author":"Chapurlat","year":"2006","journal-title":"J Bone Miner Res"},{"key":"key20180108093704_b7-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s007740200024","article-title":"Alendronate and pharmacological doses of 1 alpha OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia","volume":"20","author":"Yamomoto","year":"2002","journal-title":"J Bone Miner Metab"},{"key":"key20180108093704_b8-ol-02-06-1239","first-page":"894","article-title":"Oral bisphosphonates in polyostotic fibrous dysplasia","volume":"40","author":"Khadilkar","year":"2003","journal-title":"Indian Pediatr"},{"key":"key20180108093704_b9-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00776-004-0809-0","article-title":"Oral alendronate treatment for polyostotic fibrous dysplasia: a case report","volume":"9","author":"Kitagawa","year":"2004","journal-title":"J Orthop Sci"},{"key":"key20180108093704_b10-ol-02-06-1239","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2010-432060","article-title":"Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report","author":"Arag\u00e3o","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"key20180108093704_b11-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"A207","DOI":"10.2106\/00004623-196244020-00001","article-title":"The natural history of fibrous dysplasia. An orthopaedic, pathological, and roentgenographic study","volume":"44","author":"Harris","year":"1962","journal-title":"J Bone Joint Surg Am"},{"key":"key20180108093704_b12-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s002560050216","article-title":"Fibrous dysplasia of bone: case report with autopsy study 80 years after the original clinical recognition of the bone lesions","volume":"26","author":"Sissons","year":"1997","journal-title":"Skeletal Radiol"},{"key":"key20180108093704_b13-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s004320050190","article-title":"Fibrous dysplasia associated with intramuscular myxoma (Mazabraud's syndrome): a long-term follow-up of three cases","volume":"124","author":"Szendr\u00f3i","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180108093704_b14-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1210\/jc.2003-030050","article-title":"Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone","volume":"88","author":"Plotkin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108093704_b15-ol-02-06-1239","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1359\/JBMR.041111","article-title":"An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2011.369\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T11:07:07Z","timestamp":1515409627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2011.369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,2]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,8,2]]},"published-print":{"date-parts":[[2011,11]]}},"alternative-id":["10.3892\/ol.2011.369"],"URL":"https:\/\/doi.org\/10.3892\/ol.2011.369","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,2]]}}}